SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-021859
Filing Date
2023-06-20
Accepted
2023-06-20 16:30:27
Documents
13
Period of Report
2023-06-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43259
  Complete submission text file 0001493152-23-021859.txt   276315

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfri-20230616.xsd EX-101.SCH 4288
3 XBRL DEFINITION FILE bfri-20230616_def.xml EX-101.DEF 27600
4 XBRL LABEL FILE bfri-20230616_lab.xml EX-101.LAB 38253
5 XBRL PRESENTATION FILE bfri-20230616_pre.xml EX-101.PRE 26217
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6875
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 231025586
SIC: 2834 Pharmaceutical Preparations